Arginine and training: strength, recovery and swimming
What AAKG and L-arginine studies showed about strength, recovery and swim times.
Key points
- In men experienced in strength training, the eight-week gain in maximum bench-press weight averaged 8.82 kg with AAKG and 2.67 kg with placebo. Both groups followed the same program, so the result concerns AAKG alongside training. [1] See the evidence 1
- In the same study, no additional increase in lean soft tissue mass was found. This measure includes more than muscle. [1] See the evidence 1
- In young adults without regular strength training, L-arginine showed no advantage in soreness and ability to repeat the exercise during the three days after exertion. No additional acceleration of recovery was found for these measures. [2] See the evidence 1
- In trained swimmers and triathletes, no significant difference between groups in 100 m and 200 m swim times was found after eight days of L-arginine. No advantage was found for these distances. [3] See the evidence 1 2
Practical guide
Check the conclusions and whether they apply to your situation.
Arginine and AAKG were studied in different exercises and groups. Results should not automatically be transferred between forms.
Key points
Why these conclusions
Strength, recovery and swimming
Men aged 30–50 with training experience took 12 g of AAKG per day or placebo for eight weeks; both groups trained four times per week. Maximum bench-press weight rose by 8.82 and 2.67 kg, respectively. Certainty is low, 2 out of 4. [1]
In the same study, lean soft tissue mass increased by 0.8 kg with AAKG and 0.9 kg with placebo; no additional gain was found. This measure includes more than muscle tissue. [1]
In young adults without regular strength training, 6 g of L-arginine before exertion and subsequent tests provided no advantage in soreness or exercise repetition at 24–72 hours. [2]
Trained swimmers and triathletes took 8 g of L-arginine daily for eight days; placebo and citrulline were also compared. No significant overall difference between groups in 100 m or 200 m swim time was found. [3]
Maximum bench-press weight increased by an average of 8.82 kg with AAKG and 2.67 kg with placebo over 8 weeks (p=0.03).
| Parameter | Data |
|---|---|
| Result | Maximum bench-press weight increased by an average of 8.82 kg with AAKG and 2.67 kg with placebo over 8 weeks (p=0.03). |
| Participants | 35 men aged 30–50 with strength-training experience: 20 received AAKG, 15 placebo |
| Form | Slow-release arginine alpha-ketoglutarate (AAKG) tablets |
| Dose | 12 g AAKG per day: 4 g three times; this is about 6 g L-arginine and 6 g alpha-ketoglutarate |
| Dose basis | 12 g AAKG per day: 4 g three times; this is about 6 g L-arginine and 6 g alpha-ketoglutarate |
| Comparator | Dextrose placebo; both groups performed the same strength training four times per week |
| Duration | 8 weeks |
| Certainty | 2/4: One study with 35 participants; estimate precision is limited. Many outcomes were tested and a prespecified primary measure was not stated. The result concerns AAKG specifically alongside a strength program in trained men. |
| Volume of evidence | 1 publication on one study |
| Sources | [1] |
Over 24–72 hours, soreness and the ability to repeat the exercise recovered similarly in both groups. No advantage of arginine over placebo was found.
| Parameter | Data |
|---|---|
| Result | Over 24–72 hours, soreness and the ability to repeat the exercise recovered similarly in both groups. No advantage of arginine over placebo was found. |
| Participants | 20 healthy young adults without regular strength training, mean age 22.8 years; each group included 7 men and 3 women |
| Form | Free L-arginine powder in 200 mL of water |
| Dose | 6 g 60 minutes before the initial exertion and before each test at 24, 48 and 72 hours: four doses in total |
| Dose basis | 6 g 60 minutes before the initial exertion and before each test at 24, 48 and 72 hours: four doses in total |
| Comparator | 6 g of cornstarch in water before the same exertion and tests |
| Duration | One strength exercise session and 3 days of observation |
| Certainty | 2/4: Only 20 of 24 recruited participants completed the study. Participants and researchers did not know who received arginine; soreness was self-rated. One exertion and three days of recovery were studied in young people without regular strength training. |
| Volume of evidence | 1 publication on one study |
| Sources | [2] |
Lean soft tissue mass increased by an average of 0.8 kg with AAKG and 0.9 kg with placebo. No additional gain from the supplement was found (p=0.90); this is a body-composition measure, not muscle alone.
| Parameter | Data |
|---|---|
| Result | Lean soft tissue mass increased by an average of 0.8 kg with AAKG and 0.9 kg with placebo. No additional gain from the supplement was found (p=0.90); this is a body-composition measure, not muscle alone. |
| Participants | 35 men aged 30–50 with strength-training experience: 20 received AAKG, 15 placebo |
| Form | Slow-release arginine alpha-ketoglutarate (AAKG) tablets |
| Dose | 12 g AAKG per day: 4 g three times; this is about 6 g L-arginine and 6 g alpha-ketoglutarate |
| Dose basis | 12 g AAKG per day: 4 g three times; this is about 6 g L-arginine and 6 g alpha-ketoglutarate |
| Comparator | Dextrose placebo; both groups performed the same strength training four times per week |
| Duration | 8 weeks |
| Certainty | 2/4: One study with 35 participants; a small difference is difficult to estimate precisely. Many measures were tested; lean tissue mass was measured by DXA. The result concerns AAKG and eight weeks of strength training. |
| Volume of evidence | 1 publication on one study |
| Sources | [1] |
No advantage in 100 m swim time was found after the arginine course. The overall comparison of three groups showed no significant difference (p=0.993).
| Parameter | Data |
|---|---|
| Result | No advantage in 100 m swim time was found after the arginine course. The overall comparison of three groups showed no significant difference (p=0.993). |
| Participants | 15 trained swimmers and triathletes; 5 in the arginine group, 5 placebo and another 5 citrulline |
| Form | Free L-arginine powder in 500 mL of water |
| Dose | 8 g per day; on the final day, 1.5 hours before the swims |
| Dose basis | 8 g per day; on the final day, 1.5 hours before the swims |
| Comparator | 8 g of cellulose in water; a third group separately received citrulline |
| Duration | 8 days of use; two test visits nine days apart |
| Certainty | 2/4: Only five participants per group. Several measures were tested; swim times were measured with a stopwatch. The result concerns trained swimmers and triathletes after eight days of use. |
| Volume of evidence | 1 publication on one study |
| Sources | [3] |
No advantage in 200 m swim time was found after the arginine course. The overall comparison of three groups showed no significant difference (p=0.226).
| Parameter | Data |
|---|---|
| Result | No advantage in 200 m swim time was found after the arginine course. The overall comparison of three groups showed no significant difference (p=0.226). |
| Participants | 15 trained swimmers and triathletes; 5 in the arginine group, 5 placebo and another 5 citrulline |
| Form | Free L-arginine powder in 500 mL of water |
| Dose | 8 g per day; on the final day, 1.5 hours before the swims |
| Dose basis | 8 g per day; on the final day, 1.5 hours before the swims |
| Comparator | 8 g of cellulose in water; a third group separately received citrulline |
| Duration | 8 days of use; two test visits nine days apart |
| Certainty | 2/4: Only five participants per group. Several measures were tested; swim times were measured with a stopwatch. The result concerns trained swimmers and triathletes after eight days of use. |
| Volume of evidence | 1 publication on one study |
| Sources | [3] |
Information from the source
Information from the source
Arginine supplements are not recommended after a recent myocardial infarction. In a study of 153 patients after infarction, with a target dose of 9 g per day over six months, six people died in the arginine group and none in the placebo group; recruitment was stopped. These data concern people after infarction. Nausea, abdominal pain, diarrhea, bloating, headache, gout and allergic reactions are possible. Arginine may also lower blood pressure and increase airway inflammation and asthma symptoms; if you have asthma or allergies, discuss the supplement with a doctor before taking it. During pregnancy and breastfeeding, Health Canada recommends consulting a doctor about use. The monograph is intended for adults aged 18 and over; adult regimens in the table are not pediatric doses. If you have cardiovascular disease, discuss use with a doctor before increasing physical activity. For doses of 3 g per day or more, Health Canada separately specifies a consultation for use longer than eight weeks in this group. According to an NIH review, doses up to 9 g per day were generally well tolerated for several days or weeks. At 9–30 g per day, gastrointestinal complaints and a small reduction in blood pressure were reported more often; the safety of high doses for longer than three months remains unclear. [6] [7] [8] [9]
Sources
- Pharmacokinetics, safety, and effects on exercise performance of L-arginine alpha-ketoglutarate in trained adult men. https://pubmed.ncbi.nlm.nih.gov/16928472/
- l-Arginine supplementation does not improve muscle function during recovery from resistance exercise. https://pubmed.ncbi.nlm.nih.gov/29544063/
- Eight Days of L-Citrulline or L-Arginine Supplementation Did Not Improve 200-m and 100-m Swimming Time Trials. https://pubmed.ncbi.nlm.nih.gov/35457330/
- Long-term high-dose L-arginine supplementation in patients with vasculogenic erectile dysfunction: a multicentre, double-blind, randomized, placebo-controlled clinical trial. https://pubmed.ncbi.nlm.nih.gov/34973154/
- Effects of Oral L-Arginine on Everyday Persistent Fatigue, Sleep, and Post-Exercise Lactate Recovery in Community-Dwelling Working-Age Adults: A Double-Blind, Placebo-Controlled Randomized Trial. https://www.mdpi.com/2072-6643/18/20/3375
- Dietary Supplements for Exercise and Athletic Performance — Health Professional Fact Sheet (NIH ODS). https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/
- L-Arginine Therapy in Acute Myocardial Infarction: The Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) Randomized Clinical Trial. https://doi.org/10.1001/jama.295.1.58
- Health Canada — Natural Health Product: L-Arginine (25 July 2025). https://webprod.hc-sc.gc.ca/nhpid-bdipsn/dbImages/mono_arginine-l_english.pdf
- L-arginine (Mayo Clinic). https://www.mayoclinic.org/drugs-supplements-l-arginine/art-20364681
Methodology: Subpages evidence-led supplement pipeline v1